Hydralazine Hydrochloride
- Product NDC
- 35356-943
- 11-digit product format
- 353560943
- Labeler code
- 35356
- Product ID
- 35356-943_7b5266df-711c-4c8f-80cb-03b34e8a905e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydralazine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lake Erie Medical DBA Quality Care Products LLC
- Application
- ANDA040901
- Marketing category
- ANDA
- Marketing start
- 2010-01-01
- Marketing end
- 0000-00-00
- Substance
- HYDRALAZINE HYDROCHLORIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 35356-943-30 | 2025-01-15 | C162847 | 48780-1 | ba0f9c33-2249-a910-e053-dadaa90a0b85 | aa6f4129-361b-48df-9c32-744b0fde8234 |
| 35356-943-60 | 2025-01-15 | C162847 | 48780-1 | ba0f9c33-2249-a910-e053-dadaa90a0b85 | aa6f4129-361b-48df-9c32-744b0fde8234 |
| 35356-943-90 | 2025-01-15 | C162847 | 48780-1 | ba0f9c33-2249-a910-e053-dadaa90a0b85 | aa6f4129-361b-48df-9c32-744b0fde8234 |
| 35356-943-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2249-a910-e053-dadaa90a0b85 | aa6f4129-361b-48df-9c32-744b0fde8234 |
| 35356-943-60 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2249-a910-e053-dadaa90a0b85 | aa6f4129-361b-48df-9c32-744b0fde8234 |
| 35356-943-90 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2249-a910-e053-dadaa90a0b85 | aa6f4129-361b-48df-9c32-744b0fde8234 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 35356-943-30 | EA - Each | 35356-943 | 37376165-10f8-4a50-b94a-b4bc3b2e5071 | 1 | 2014-01-04 |
| 35356-943-60 | EA - Each | 35356-943 | 137f8f0d-d612-45a5-899e-8bf32ea7e1ba | 1 | 2013-09-04 |